DFTX earnings: a positive outcome, +11.4%

On November 7, 2024, Definium Therapeutics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +11.4% in the window around the event. It had already run +14.8% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.